Hepa-Merz

Medicinal product

(Invented) name

Hepa-Merz

Active substance (s)

L-ornitino L-aspartatas

Strength

5 g/10 ml

Pharmaceutical form

koncentratas infuziniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

A05BA, Liver therapy

Marketing authorisation holder

Merz Pharmaceuticals GmbH, Vokietija

Date of authorisation

1994-06-02

Date of renewal

2014-01-31

Documents

0572_1 Hepa_Merz konc_inf II PL 201201.docx

0572_1 Pakuotės lapelis 201201.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Vienoje ampulėje (10 ml tirpalo) yra	10 ml
L-ornitino L-aspartatas	5 g

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
18058	21785	1021785	ampulė	10 ml N10		Receptinis	LT/1/94/0572/001	Tiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2014-01-31	Perregistruotas
1994-06-02	Registruotas